Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson’s disease: A pilot randomized clinical trial (the SkinHeRo study)

Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson’s disease: A pilot randomized clinical trial (the SkinHeRo study)

Introduction: The rotigotine transdermal patch (RTP) is a dopamine agonist used to treat Parkinson’s disease (PD) but is sometimes discontinued because of application site reactions (ASRs). We aimed to investigate the effect of a heparinoid-containing product (HCP) for preventing ASRs due to the RTP...

Full description

Bibliographic Details
Main Authors: Jinsoo Koh, Maiko Takahashi, Mayumi Sakata, Masaaki Yasui, Shoko Yorozu, Hidefumi Ito
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Clinical Parkinsonism & Related Disorders
Subjects:
Parkinson’s disease
Skin
Moisturizing
Quality of life, dopamine agonist
Patch
Online Access:http://www.sciencedirect.com/science/article/pii/S2590112521000177

Internet

http://www.sciencedirect.com/science/article/pii/S2590112521000177

Similar Items